{"id":12730,"date":"2019-11-08T22:46:00","date_gmt":"2019-11-08T13:46:00","guid":{"rendered":"https:\/\/microncro.com\/?p=12730"},"modified":"2026-05-18T15:54:32","modified_gmt":"2026-05-18T06:54:32","slug":"video-fda-guidance-part-2","status":"publish","type":"post","link":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/","title":{"rendered":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d"},"content":{"rendered":"\n<p class=\"is-small-size\">In this video we briefly explain the overview of FDA Guidance, Clinical Trial Imaging Endpoint Process Standards continuing from last time. In addition, we introduce our experience how we organize high quality imaging study.<\/p>\n\n\n\n<p class=\"is-small-size\"><a href=\"https:\/\/microncro.com\/en\/resources\/video-fda-guidance-part-2\/\" type=\"link\" id=\"https:\/\/microncro.com\/en\/resources\/video-fda-guidance-part-2\/\" target=\"_blank\" rel=\"noreferrer noopener\">FDA Guidance Clinical Trial Imaging Endpoint Process Standards Part2 -Micron\u2019s experience-<\/a><\/p>\n\n\n\n\n<div class=\"micron-share\">\n\t<div class=\"micron-share-inner\">\n\t\t<h2 class=\"micron-share-title\">Share<\/h2>\n\t\t<ul class=\"micron-share-buttons\">\n\t\t\t<li><a class=\"micron-share-button-linkedin\" href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/\" rel=\"nofollow\" target=\"_blank\">LinkedIn \u3067\u30b7\u30a7\u30a2\u3059\u308b<\/a><\/li>\n\t\t<\/ul>\n\t<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In this video we briefly explain the overview of FDA Guidance, Clinical Trial Imaging Endpoint Process Standards continuing from last time. In addition, we introduce our experience how we organize high quality imaging study. FDA Guidance Clinical Trial Imaging Endpoint Process Standards Part2 -Micron\u2019s experience-<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/microncro.com\/?p=12730","footnotes":""},"categories":[31],"class_list":["post-12730","post","type-post","status-publish","format-standard","hentry","category-news","en-US"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | Micron, Inc. | Molecular Imaging CRO Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | Micron, Inc. | Molecular Imaging CRO Network\" \/>\n<meta property=\"og:description\" content=\"In this video we briefly explain the overview of FDA Guidance, Clinical Trial Imaging Endpoint Process Standards continuing from last time. In addition, we introduce our experience how we organize high quality imaging study. FDA Guidance Clinical Trial Imaging Endpoint Process Standards Part2 -Micron\u2019s experience-\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Micron, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-08T13:46:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-18T06:54:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"info@digitalcube.jp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info@digitalcube.jp\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/\"},\"author\":{\"name\":\"info@digitalcube.jp\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/person\\\/122c381484536eeb18bd40a8b8e47aaf\"},\"headline\":\"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d\",\"datePublished\":\"2019-11-08T13:46:00+00:00\",\"dateModified\":\"2026-05-18T06:54:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/\"},\"wordCount\":54,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/\",\"name\":\"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3 | Molecular Imaging CRO Network\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\"},\"datePublished\":\"2019-11-08T13:46:00+00:00\",\"dateModified\":\"2026-05-18T06:54:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video-fda-guidance-part-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/microncro.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"description\":\"Molecular Imaging CRO Network\",\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/microncro.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"contentUrl\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"width\":1200,\"height\":630,\"caption\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\"},\"image\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/person\\\/122c381484536eeb18bd40a8b8e47aaf\",\"name\":\"info@digitalcube.jp\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"caption\":\"info@digitalcube.jp\"},\"sameAs\":[\"https:\\\/\\\/microncro.com\"],\"url\":\"https:\\\/\\\/microncro.com\\\/archives\\\/post\\\/author\\\/infodigitalcube-jp\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | Micron, Inc. | Molecular Imaging CRO Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/","og_locale":"en_US","og_type":"article","og_title":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | Micron, Inc. | Molecular Imaging CRO Network","og_description":"In this video we briefly explain the overview of FDA Guidance, Clinical Trial Imaging Endpoint Process Standards continuing from last time. In addition, we introduce our experience how we organize high quality imaging study. FDA Guidance Clinical Trial Imaging Endpoint Process Standards Part2 -Micron\u2019s experience-","og_url":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/","og_site_name":"Micron, Inc.","article_published_time":"2019-11-08T13:46:00+00:00","article_modified_time":"2026-05-18T06:54:32+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","type":"image\/png"}],"author":"info@digitalcube.jp","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info@digitalcube.jp","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/#article","isPartOf":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/"},"author":{"name":"info@digitalcube.jp","@id":"https:\/\/microncro.com\/#\/schema\/person\/122c381484536eeb18bd40a8b8e47aaf"},"headline":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d","datePublished":"2019-11-08T13:46:00+00:00","dateModified":"2026-05-18T06:54:32+00:00","mainEntityOfPage":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/"},"wordCount":54,"commentCount":0,"publisher":{"@id":"https:\/\/microncro.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/","url":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/","name":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d | \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3 | Molecular Imaging CRO Network","isPartOf":{"@id":"https:\/\/microncro.com\/#website"},"datePublished":"2019-11-08T13:46:00+00:00","dateModified":"2026-05-18T06:54:32+00:00","breadcrumb":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microncro.com\/en\/archives\/post\/video-fda-guidance-part-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microncro.com\/en\/"},{"@type":"ListItem","position":2,"name":"Video broadcasting \u201cFDA Guidance Part 2, Micron\u2019s experience\u201d"}]},{"@type":"WebSite","@id":"https:\/\/microncro.com\/#website","url":"https:\/\/microncro.com\/","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","description":"Molecular Imaging CRO Network","publisher":{"@id":"https:\/\/microncro.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microncro.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microncro.com\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","url":"https:\/\/microncro.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/","url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","contentUrl":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","width":1200,"height":630,"caption":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3"},"image":{"@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/microncro.com\/#\/schema\/person\/122c381484536eeb18bd40a8b8e47aaf","name":"info@digitalcube.jp","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","caption":"info@digitalcube.jp"},"sameAs":["https:\/\/microncro.com"],"url":"https:\/\/microncro.com\/archives\/post\/author\/infodigitalcube-jp\/"}]}},"_links":{"self":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/12730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/comments?post=12730"}],"version-history":[{"count":3,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/12730\/revisions"}],"predecessor-version":[{"id":13798,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/12730\/revisions\/13798"}],"wp:attachment":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/media?parent=12730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/categories?post=12730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}